Telormedix Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
Telormedix General Information
Description
Developer of biopharmaceutical drugs intended to treat cancer and infectious diseases. The company's drugs are developed with a new formulation of a clinically active small molecule compound with a known and favorable safety profile and a specific immunotherapeutic target, enabling cancer patients to get more advanced treatment with a better medical outcome.
Contact Information
Website
www.telormedix.comCorporate Office
- Via della Posta 10
- 6934 Bioggio
- Switzerland
Corporate Office
- Via della Posta 10
- 6934 Bioggio
- Switzerland
Telormedix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Merger/Acquisition | 01-Jan-2015 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series B) | 02-Dec-2013 | Completed | Generating Revenue | |||
| 10. Grant | 07-Aug-2013 | Completed | Generating Revenue | |||
| 9. Grant | 01-Dec-2012 | Completed | Startup | |||
| 8. Grant | 04-Jun-2012 | Completed | Startup | |||
| 7. Grant | 26-Mar-2012 | Completed | Startup | |||
| 6. Later Stage VC | 10-Jan-2012 | Completed | Startup | |||
| 5. Grant | 01-Jan-2012 | Completed | Startup | |||
| 4. Grant | 05-Sep-2011 | $1.05M | $19M | Completed | Startup | |
| 3. Secondary Transaction - Private | 01-Jan-2011 | $19M | Completed | Startup |
Telormedix Comparisons
Industry
Financing
Details
Telormedix Competitors (15)
One of Telormedix’s 15 competitors is Pfizer (Vienna), a Corporation company based in Vienna, Austria.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
| Gesynta Pharma | Venture Capital-Backed | Stockholm, Sweden | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Aytu Biopharma | Formerly VC-backed | Denver, CO |
Telormedix Patents
Telormedix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2015104030-A1 | Pharmaceutical compositions comprising imiquimod for use in the treatment of carcinoma in situ of the bladder | Inactive | 10-Jan-2014 | ||
| WO-2015104219-A1 | Pharmaceutical compositions comprising imiquimod for use in the treatment of carcinoma in situ of the bladder | Inactive | 10-Jan-2014 | ||
| WO-2015036044-A1 | Cationic lipid vehicles for delivery of tlr7 agonists for specific targeting of human cd14+ monocytes in whole blood | Inactive | 13-Sep-2013 | ||
| WO-2014053222-A1 | Phospholipid drug analogs | Inactive | 01-Oct-2012 | ||
| US-20120083473-A1 | Treatment of conditions by toll-like receptor modulators | Inactive | 21-Sep-2010 | A61K31/52 |
Telormedix Signals
Telormedix Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aravis | Growth/Expansion | Minority | ||
| Assicurazioni Generali | Corporation | Minority | ||
| BSI | Investment Bank | Minority | ||
| Nextech Invest | Venture Capital | Minority | ||
| ProQuest Investments | Venture Capital | Minority |
Telormedix Investments (1)
Telormedix’s most recent deal was a Later Stage VC with Urogen Pharma for . The deal was made on 22-May-2013.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Urogen Pharma | 22-May-2013 | Later Stage VC | Drug Delivery |
Telormedix FAQs
-
When was Telormedix founded?
Telormedix was founded in 2007.
-
Where is Telormedix headquartered?
Telormedix is headquartered in Bioggio, Switzerland.
-
What is the size of Telormedix?
Telormedix has 7 total employees.
-
What industry is Telormedix in?
Telormedix’s primary industry is Pharmaceuticals.
-
Is Telormedix a private or public company?
Telormedix is a Private company.
-
What is Telormedix’s current revenue?
The current revenue for Telormedix is .
-
How much funding has Telormedix raised over time?
Telormedix has raised $33.4M.
-
Who are Telormedix’s investors?
Aravis, Assicurazioni Generali, BSI, Nextech Invest, and ProQuest Investments are 5 of 6 investors who have invested in Telormedix.
-
Who are Telormedix’s competitors?
Pfizer (Vienna), Pfizer Pakistan, Gesynta Pharma, Ability Pharma, and Aytu Biopharma are some of the 15 competitors of Telormedix.
-
When was Telormedix acquired?
Telormedix was acquired on 01-Jan-2015.
-
Who acquired Telormedix?
Telormedix was acquired by Urogen Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process